Tasmanians experience the highest rates of heart disease, with heart failure among the top six causes of preventable hospitalisations in Tasmania.
The Tasmanian heart failure project was a collaboration coordinated by the Australian Healthcare and Hospitals Association (AHHA), led by Primary Health Tasmania and Heart Foundation Tasmania with support from Novartis Pharmaceuticals Australia and sponsorship from the Tasmanian Department of Health. The vision was to conduct a project to reduce preventable heart failure hospitalisations in Tasmania. The main focus of the project was to support optimal management of heart failure in the primary care setting.
